← Leaderboards
Yoshihiro Izumiya
University Of California At Davis
$11,629,084
Attributed
$14,083,407
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,083,407 · 13
By mechanism
R01$11,622,165 · 7
R21$1,448,242 · 4
U01$990,000 · 1
R13$23,000 · 1
Top collaborators
- Yuanpei Li6 shared
- R. Holland Cheng3 shared
- Kit S Lam3 shared
- Tetsushi Yoshikawa3 shared
Most similar at University Of California At Davis
Same institution · by research overlap
- Kit S Lam$32,497,491
- Tetsushi Yoshikawa$198,287
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMolecularMediatingGenetic TranscriptionLinkMalignant NeoplasmsViralHuman Herpesvirus 8Gene ExpressionKaposi SarcomaMulticentric Angiofollicular Lymphoid HyperplasiaInfectionProteinsVirusGenomeB-Cell LymphomasComplexBindingTranscription FactorMutantTissuesBiologicalPrimary Effusion LymphomaStructure
Grant awards (39)
Studies on Viral Enhancer for Latency-Lytic Switch$564,698
R01 · FY2025 · CA · contact PI
Studies on Epigenetically Active Latent Chromatin Maintenance$517,813
R01 · FY2025 · AI · contact PI
KSHV Replication and Trained Immunity$505,056
R01 · FY2025 · DE · contact PI
Characterization of KSHV-Associated Disease Specific Gene Therapy$188,169
R21 · FY2025 · CA · contact PI
Studies on Inherited Chromosomally Integrated HHV-6 with Patient-derived Induced Pluripotent Stem Cells$126,715
R21 · FY2025 · AI · contact PI
Studies on Inherited Chromosomally Integrated HHV-6 with Patient-derived Induced Pluripotent Stem Cells$50,000
R21 · FY2025 · AI · contact PI
27th International Conference on Kaposi's Sarcoma associated Herpesvirus and Related Agents$23,000
R13 · FY2025 · CA · contact PI
Studies on Epigenetically Active Latent Chromatin Maintenance$532,446
R01 · FY2024 · AI · contact PI
Studies on Inherited Chromosomally Integrated HHV-6 with Patient-derived Induced Pluripotent Stem Cells$219,858
R21 · FY2024 · AI · contact PI
Studies on Epigenetically Active Latent Chromatin Maintenance$529,822
R01 · FY2023 · AI · contact PI
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$537,395
R01 · FY2022 · CA · contact PI
Studies on Epigenetically Active Latent Chromatin Maintenance$505,165
R01 · FY2022 · AI · contact PI
Spatiotemporal Gene Regulation and KSHV Replication$359,138
R01 · FY2022 · CA · contact PI
Development of Precision Analyses to Reveal Hit&RunÃÂÃÂ Effects$196,250
R21 · FY2022 · AI · contact PI
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$537,395
R01 · FY2021 · CA · contact PI
Spatiotemporal Gene Regulation and KSHV Replication$359,138
R01 · FY2021 · CA · contact PI
Development of Precision Analyses to Reveal "Hit&Run" Effects$235,500
R21 · FY2021 · AI · contact PI
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$743,574
R01 · FY2020 · CA · contact PI
KSHV Replication in Oral Epithelial Cells$392,500
R01 · FY2020 · DE · contact PI
Spatiotemporal Gene Regulation and KSHV Replication$359,138
R01 · FY2020 · CA · contact PI
Assembly of Transcriptional Factories by Viral Non-coding RNA Expression$196,250
R21 · FY2020 · AI · contact PI
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$537,395
R01 · FY2019 · CA · contact PI
KSHV Replication in Oral Epithelial Cells$392,500
R01 · FY2019 · DE · contact PI
Spatiotemporal Gene Regulation and KSHV Replication$348,363
R01 · FY2019 · CA · contact PI
Assembly of Transcriptional Factories by Viral Non-coding RNA Expression$235,500
R21 · FY2019 · AI · contact PI
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$206,179
R01 · FY2019 · CA · contact PI
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies$630,136
R01 · FY2018 · CA · contact PI
KSHV Replication in Oral Epithelial Cells$392,500
R01 · FY2018 · DE · contact PI
Spatiotemporal Gene Regulation and KSHV Replication$359,138
R01 · FY2018 · CA · contact PI
KSHV Replication in Oral Epithelial Cells$392,500
R01 · FY2017 · DE · contact PI
Genetically Encoded Small Illuminants for 4D nucleome imaging$330,000
U01 · FY2017 · EB
KSHV Replication in Oral Epithelial Cells$392,083
R01 · FY2016 · DE · contact PI
Genetically Encoded Small Illuminants for 4D nucleome imaging$330,000
U01 · FY2016 · EB
Genetically Encoded Small Illuminants for 4D nucleome imaging$330,000
U01 · FY2015 · EB
K-Rta as a Novel SUMO and Epigenetic Regulator$300,665
R01 · FY2014 · CA · contact PI
K-Rta as a Novel SUMO and Epigenetic Regulator$291,367
R01 · FY2013 · CA · contact PI
K-Rta as a Novel SUMO and Epigenetic Regulator$309,796
R01 · FY2012 · CA · contact PI
K-Rta as a Novel SUMO and Epigenetic Regulator$308,790
R01 · FY2011 · CA · contact PI
K-Rta as a Novel SUMO and Epigenetic Regulator$317,475
R01 · FY2010 · CA · contact PI